Analyst consensus rating
Precision BioSciences Analyst Rating: Strong Buy
Direct answer
Precision BioSciences's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $29.40.
Forecast evidence checked September 7, 2026.
Get free Precision BioSciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.47
- Average price target
- $29.40
- High price target
- $60.00
- Low price target
- $18.00
- Low target gap
- +141%
- Target upside
- +293.6%
- High target gap
- +703.2%
- Target range width
- 562.2%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Precision BioSciences?
Precision BioSciences has a verified Strong Buy consensus. The same dataset has an average price target of $29.40.
How far are Precision BioSciences's low and high targets from the recorded price?
The low target implies +141%, while the high target implies +703.2%.
How many analysts are included in Precision BioSciences's consensus?
The verified consensus includes 5 analysts.
How is Precision BioSciences's target upside or downside calculated?
The average target of $29.40 is divided by the recorded price of $7.47, then one is subtracted to produce +293.6%. This does not guarantee a future return.
When was Precision BioSciences's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.